NeuroSense Therapeutics Ltd. (NRSN) Capital expenditures 2021–2025
NeuroSense Therapeutics Ltd. (NRSN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$8,000FY2025 · since FY2021: $17,000 → $8,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $8,000 | +166.7% |
| FY2024 | $3,000 | -89.7% |
| FY2023 | $29,000 | -58.6% |
| FY2022 | $70,000 | +311.8% |
| FY2021 | $17,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice